Simplify Logo

Full-Time

Manager – Inspection Management

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

Healthcare
Biotechnology

Senior, Expert

Cambridge, MA, USA + 2 more

More locations: Princeton, NJ, USA | Bethesda, MD, USA

Hybrid role with specific locations in Cambridge, Massachusetts; Princeton, New Jersey; and Bethesda, Maryland.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Management
Requirements
  • BS/BA, MS or PhD and a minimum of 10, 8, 6 years’ experience, respectively, in Biotech, Pharma or Clinical Research Organization.
  • 8+ years experience in Inspection Management/Audit/Quality Management
Responsibilities
  • Partner closely with members of R&D to lead and support the successful and compliant execution of Moderna regulatory authority inspection activities in the region
  • Actively participate as a key member of the inspection team in Regulatory Authority inspections (GCP, GVP) within the region including inspection planning, logistics, preparation training and support; actively support during the inspection and provide expert guidance and direction in development of responses to inspection observations and regulatory agency questions resulting from inspections.
  • Ensure any critical and major inspection findings have appropriate Corrective and Preventative Actions (CAPA) and are tracked to completion and verification of effectiveness.
  • Review and provide input into study team inspection readiness activities, storyboards, etc.
  • Provide education, guidance and/or inspection management training for GCP functional areas and clinical operations teams.
  • Provide input into the issue management program to ensure early detection of issues, development of appropriate and robust corrective and preventative actions (CAPA), tracking of CAPA completion, and assessment of effectiveness is attained.
  • Execute and report GCP investigator site, study, system/process, and vendor audits and GVP vendors, system, affiliate, partner audits, as necessary, and work with Moderna staff to ensure the proposed corrective and preventative actions received from the auditees are appropriate and implemented.
  • Contribute to the R&D Quality Regulatory Intelligence program
  • Contribute to the R&D Quality Newsletter
  • Participate in Moderna projects and initiatives
  • Contribute to the continuing development of a quality culture at Moderna
  • Additional duties as may be assigned from time to time

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

8%

2 year growth

55%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.